 Jill Fattor
Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lumbar Vertebrae | 3 | 2018 | 252 | 0.560 |
Why?
| | Physical Endurance | 9 | 2013 | 278 | 0.510 |
Why?
| | Total Disc Replacement | 1 | 2016 | 12 | 0.480 |
Why?
| | Lactic Acid | 9 | 2013 | 302 | 0.470 |
Why?
| | Exercise | 14 | 2013 | 2193 | 0.470 |
Why?
| | Intervertebral Disc | 1 | 2016 | 36 | 0.460 |
Why?
| | Models, Anatomic | 1 | 2016 | 84 | 0.460 |
Why?
| | Recovery of Function | 3 | 2016 | 706 | 0.380 |
Why?
| | Lactates | 2 | 2006 | 83 | 0.230 |
Why?
| | Oxygen Consumption | 10 | 2013 | 724 | 0.230 |
Why?
| | Physical Fitness | 3 | 2013 | 209 | 0.220 |
Why?
| | Epinephrine | 2 | 2009 | 155 | 0.220 |
Why?
| | Energy Metabolism | 10 | 2010 | 935 | 0.210 |
Why?
| | Norepinephrine | 1 | 2004 | 196 | 0.200 |
Why?
| | Gluconeogenesis | 4 | 2013 | 83 | 0.200 |
Why?
| | Postmenopause | 3 | 2010 | 391 | 0.190 |
Why?
| | Indocyanine Green | 1 | 2001 | 42 | 0.180 |
Why?
| | Blood Glucose | 7 | 2013 | 2312 | 0.170 |
Why?
| | Fatty Acids, Nonesterified | 4 | 2010 | 158 | 0.160 |
Why?
| | Muscle, Skeletal | 5 | 2007 | 1792 | 0.150 |
Why?
| | Lipolysis | 2 | 2010 | 46 | 0.140 |
Why?
| | Physical Exertion | 3 | 2004 | 207 | 0.140 |
Why?
| | Spondylolisthesis | 1 | 2018 | 8 | 0.140 |
Why?
| | Glycogenolysis | 3 | 2013 | 4 | 0.140 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2018 | 33 | 0.140 |
Why?
| | Antioxidants | 3 | 2006 | 549 | 0.130 |
Why?
| | Exercise Test | 6 | 2013 | 634 | 0.130 |
Why?
| | Mechanical Phenomena | 1 | 2018 | 80 | 0.130 |
Why?
| | Carbon Dioxide | 3 | 2013 | 242 | 0.130 |
Why?
| | Polyethylene Glycols | 1 | 2001 | 649 | 0.120 |
Why?
| | Finite Element Analysis | 1 | 2016 | 67 | 0.120 |
Why?
| | Triglycerides | 2 | 2010 | 512 | 0.120 |
Why?
| | Glycerol | 4 | 2010 | 90 | 0.110 |
Why?
| | Spinal Fusion | 1 | 2018 | 260 | 0.110 |
Why?
| | Anaerobic Threshold | 1 | 2013 | 28 | 0.100 |
Why?
| | Cardiovascular Physiological Phenomena | 2 | 2012 | 48 | 0.100 |
Why?
| | Lipid Peroxidation | 4 | 2007 | 160 | 0.100 |
Why?
| | Rest | 6 | 2012 | 124 | 0.100 |
Why?
| | Physical Conditioning, Human | 1 | 2013 | 39 | 0.090 |
Why?
| | Hypoxia | 2 | 2013 | 1199 | 0.090 |
Why?
| | Respiration | 3 | 2009 | 206 | 0.090 |
Why?
| | Imaging, Three-Dimensional | 1 | 2016 | 582 | 0.090 |
Why?
| | Models, Biological | 2 | 2018 | 1820 | 0.090 |
Why?
| | Altitude | 2 | 2006 | 473 | 0.090 |
Why?
| | Oxidation-Reduction | 6 | 2013 | 1084 | 0.080 |
Why?
| | Adult | 20 | 2018 | 40262 | 0.080 |
Why?
| | Glucose | 2 | 2012 | 1046 | 0.080 |
Why?
| | Insulin | 4 | 2013 | 2501 | 0.070 |
Why?
| | Humans | 26 | 2018 | 144261 | 0.060 |
Why?
| | Fatty Acids | 2 | 2007 | 450 | 0.060 |
Why?
| | Sodium Bicarbonate | 1 | 2007 | 47 | 0.060 |
Why?
| | Male | 21 | 2018 | 72035 | 0.060 |
Why?
| | Pulmonary Ventilation | 1 | 2007 | 83 | 0.060 |
Why?
| | Kinetics | 4 | 2013 | 1627 | 0.060 |
Why?
| | Maximal Voluntary Ventilation | 1 | 2006 | 9 | 0.060 |
Why?
| | Lipid Metabolism | 2 | 2006 | 525 | 0.060 |
Why?
| | Liver | 2 | 2012 | 1884 | 0.060 |
Why?
| | Cholesterol, HDL | 1 | 2006 | 194 | 0.060 |
Why?
| | Sodium Lactate | 1 | 2004 | 5 | 0.050 |
Why?
| | Acid-Base Equilibrium | 1 | 2004 | 24 | 0.050 |
Why?
| | Cholesterol, LDL | 1 | 2006 | 353 | 0.050 |
Why?
| | C-Reactive Protein | 1 | 2006 | 416 | 0.050 |
Why?
| | Sympathetic Nervous System | 1 | 2004 | 178 | 0.050 |
Why?
| | Muscle Contraction | 1 | 2006 | 428 | 0.050 |
Why?
| | Altitude Sickness | 1 | 2004 | 141 | 0.050 |
Why?
| | Blood Proteins | 1 | 2004 | 249 | 0.050 |
Why?
| | Heart Rate | 2 | 2006 | 849 | 0.050 |
Why?
| | Infusions, Intravenous | 3 | 2010 | 423 | 0.050 |
Why?
| | Indicator Dilution Techniques | 1 | 2001 | 12 | 0.040 |
Why?
| | Spectrophotometry | 1 | 2001 | 60 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2006 | 780 | 0.040 |
Why?
| | Indicators and Reagents | 1 | 2001 | 106 | 0.040 |
Why?
| | Young Adult | 5 | 2018 | 13990 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2006 | 1217 | 0.040 |
Why?
| | Metabolic Clearance Rate | 2 | 2013 | 114 | 0.040 |
Why?
| | Leg | 3 | 2007 | 239 | 0.040 |
Why?
| | Plasma | 1 | 2001 | 224 | 0.040 |
Why?
| | Aging | 1 | 2010 | 1964 | 0.040 |
Why?
| | Palmitic Acid | 2 | 2010 | 42 | 0.040 |
Why?
| | Carbon Isotopes | 2 | 2010 | 144 | 0.040 |
Why?
| | Apolipoproteins | 2 | 2010 | 37 | 0.030 |
Why?
| | Lumbosacral Region | 1 | 2018 | 59 | 0.030 |
Why?
| | Lordosis | 1 | 2018 | 16 | 0.030 |
Why?
| | Cardiovascular Diseases | 1 | 2010 | 2134 | 0.030 |
Why?
| | Operative Time | 1 | 2018 | 175 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2004 | 1339 | 0.030 |
Why?
| | Blood Loss, Surgical | 1 | 2018 | 112 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2018 | 218 | 0.030 |
Why?
| | Middle Aged | 6 | 2018 | 35762 | 0.030 |
Why?
| | Posture | 1 | 2018 | 196 | 0.030 |
Why?
| | Elective Surgical Procedures | 1 | 2018 | 201 | 0.030 |
Why?
| | Double-Blind Method | 3 | 2006 | 2025 | 0.030 |
Why?
| | Low Back Pain | 1 | 2018 | 106 | 0.030 |
Why?
| | Female | 10 | 2018 | 77976 | 0.030 |
Why?
| | Blood Pressure | 1 | 2002 | 1759 | 0.030 |
Why?
| | Adolescent | 5 | 2007 | 22281 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2018 | 842 | 0.030 |
Why?
| | Regional Blood Flow | 2 | 2006 | 512 | 0.030 |
Why?
| | Body Weight | 2 | 2010 | 976 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2006 | 1304 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2013 | 311 | 0.020 |
Why?
| | Pressure | 1 | 2013 | 225 | 0.020 |
Why?
| | Glucose Tolerance Test | 1 | 2013 | 360 | 0.020 |
Why?
| | Sex Characteristics | 2 | 2008 | 789 | 0.020 |
Why?
| | Hormones | 1 | 2012 | 134 | 0.020 |
Why?
| | Body Composition | 2 | 2006 | 704 | 0.020 |
Why?
| | Homeostasis | 2 | 2008 | 640 | 0.020 |
Why?
| | Sex Factors | 2 | 2010 | 2096 | 0.020 |
Why?
| | Fasting | 1 | 2012 | 276 | 0.020 |
Why?
| | Esterification | 1 | 2010 | 9 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2840 | 0.020 |
Why?
| | Diet Records | 1 | 2010 | 85 | 0.020 |
Why?
| | Bicycling | 1 | 2010 | 120 | 0.020 |
Why?
| | Basal Metabolism | 1 | 2009 | 62 | 0.020 |
Why?
| | Walking | 1 | 2013 | 545 | 0.020 |
Why?
| | Glucagon | 1 | 2009 | 112 | 0.020 |
Why?
| | Cholesterol | 1 | 2010 | 399 | 0.020 |
Why?
| | Oxygen | 1 | 2013 | 995 | 0.020 |
Why?
| | Down-Regulation | 1 | 2010 | 627 | 0.020 |
Why?
| | Time Factors | 2 | 2010 | 7155 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2730 | 0.020 |
Why?
| | Growth Hormone | 1 | 2007 | 92 | 0.020 |
Why?
| | Whole-Body Counting | 1 | 2006 | 7 | 0.020 |
Why?
| | Pyruvates | 1 | 2006 | 24 | 0.020 |
Why?
| | Body Weights and Measures | 1 | 2006 | 36 | 0.020 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2006 | 115 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 1 | 2006 | 119 | 0.010 |
Why?
| | Femoral Artery | 1 | 2007 | 189 | 0.010 |
Why?
| | Lipoproteins, LDL | 1 | 2006 | 114 | 0.010 |
Why?
| | Catecholamines | 1 | 2006 | 87 | 0.010 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2006 | 97 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2018 | 2916 | 0.010 |
Why?
| | Muscle Fatigue | 1 | 2006 | 97 | 0.010 |
Why?
| | Hydrocortisone | 1 | 2007 | 304 | 0.010 |
Why?
| | Insulin Resistance | 1 | 2013 | 1232 | 0.010 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2006 | 214 | 0.010 |
Why?
| | Workload | 1 | 2006 | 170 | 0.010 |
Why?
| | Hematocrit | 1 | 2004 | 108 | 0.010 |
Why?
| | Placebos | 1 | 2004 | 192 | 0.010 |
Why?
| | Glycolysis | 1 | 2006 | 339 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2018 | 11643 | 0.010 |
Why?
| | Energy Intake | 1 | 2006 | 499 | 0.010 |
Why?
| | Glycogen | 1 | 2002 | 54 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 2002 | 167 | 0.010 |
Why?
| | DNA Damage | 1 | 2004 | 428 | 0.010 |
Why?
| | Reference Values | 1 | 2002 | 797 | 0.010 |
Why?
| | Adaptation, Physiological | 1 | 2004 | 569 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2018 | 17009 | 0.010 |
Why?
| | Body Mass Index | 1 | 2008 | 2420 | 0.010 |
Why?
| | Heart | 1 | 2002 | 633 | 0.010 |
Why?
| | Biomarkers | 1 | 2010 | 4254 | 0.010 |
Why?
| | Aged | 1 | 2018 | 25850 | 0.010 |
Why?
| | Weight Loss | 1 | 2002 | 832 | 0.010 |
Why?
| | Diet | 1 | 2004 | 1271 | 0.010 |
Why?
| | Prospective Studies | 1 | 2006 | 7970 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2006 | 6021 | 0.010 |
Why?
| | Animals | 1 | 2006 | 38030 | 0.000 |
Why?
|
|
Fattor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|